在COVID-19期间加速治疗开发:洞察力,监管策略和建议,为未来的流行病准备做好准备
Miyuki Katayama1, Mayumi Shikano2
1Graduate School of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Frontiers in medicine
|April 30, 2025
概括
分析COVID-19治疗方法揭示了更快的药物开发策略. 具有先前数据的现有药物提供了优势,但新的分子实体对新型疾病也至关重要. 为应对未来的流行病做好准备,需要一个灵活的监管框架.
科学领域:
- 制药科学 制药科学
- 临床发展 临床发展
- 流行病的准备 流行病的准备
背景情况:
- COVID-19治疗药物的开发迅速发生.
- 缺乏对这种快速发展的系统评估.
- 分析旨在确定缩短未来流行病临床开发的策略.
研究的目的:
- 分析COVID-19治疗药物的临床开发方法.
- 确定加速药物开发时间表的策略.
- 为未来的流行病应对做好准备提供信息.
主要方法:
- 审查了美国FDA对14种COVID-19治疗药物的紧急使用授权 (EUA) 文件.
- 检查了临床开发时间,监管审查时间,并提交了 EUA 的数据.
- 评估策略,如适应性试验设计和分阶段开发.
主要成果:
- 有现有数据的六种产品比新分子实体需要的研究少.
- 所有产品都包括安慰剂对照研究,并符合规定的数据要求.
- 通过的临床开发措施包括适应性协议和剂量调整.
结论:
- 利用现有的药物数据可以加快批准.
- 对新分子实体的早期批准对于新型病原体至关重要.
- 对于未来的流行病,建议建立一个候选者识别,信息管理和监管灵活性的框架.
相关概念视频
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Drug Administration and Therapy Phases: Overview
377
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
377
Steps in Outbreak Investigation
90
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
90
Issues And Trends In Healthcare Delivery System
5.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.5K


